Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MYO7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
CARD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SERPINE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM61 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35F6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100294033 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH3TC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPARD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAF3IP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR87 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DOLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on